Show simple item record

dc.contributor.authorMcKeever, Tricia
dc.contributor.authorMortimer, Kevin
dc.contributor.authorWilson, Andrew
dc.contributor.authorWalker, Samantha
dc.contributor.authorBrightling, Christopher
dc.contributor.authorSkeggs, Andrew
dc.contributor.authorPavord, Ian D.
dc.contributor.authorPrice, David B.
dc.contributor.authorDuley, Lelia
dc.contributor.authorThomas, Mike
dc.contributor.authorBradshaw, Lucy
dc.contributor.authorHiggins, Bernard
dc.contributor.authorHaydock, Rebecca
dc.contributor.authorMitchell, Eleanor J
dc.contributor.authorDevereux, Graham
dc.contributor.authorHarrison, Timothy
dc.date.accessioned2018-09-03T23:02:36Z
dc.date.available2018-09-03T23:02:36Z
dc.date.issued2018-03-08
dc.identifier.citationMcKeever , T , Mortimer , K , Wilson , A , Walker , S , Brightling , C , Skeggs , A , Pavord , I D , Price , D B , Duley , L , Thomas , M , Bradshaw , L , Higgins , B , Haydock , R , Mitchell , E J , Devereux , G & Harrison , T 2018 , ' Quadrupling Inhaled Gluococorticoid Dose To Abort Asthma Exacerbations ' , The New England Journal of Medicine , vol. 378 , no. 10 , pp. 902-910 . https://doi.org/10.1056/NEJMoa1714257en
dc.identifier.issn0028-4793
dc.identifier.otherPURE: 115118509
dc.identifier.otherPURE UUID: 0e610000-6e2d-4ce3-868d-8ef1081a0e13
dc.identifier.otherScopus: 85043573701
dc.identifier.urihttp://hdl.handle.net/2164/11041
dc.descriptionSupported by the Health Technology Assessment Programme of the National Institute for Health Research. We thank the trial participants, all the staff at the trial sites and the Nottingham Clinical Trial Unit who managed the trial, the members of the independent trial steering committee (Philip Ind [chair], consultant respiratory physician, Imperial College Healthcare NHS Trust; Adel Mansur, consultant physician, Birmingham Heartlands Hospital; Jacqui Cooper, chronic obstructive pulmonary disease–respiratory team leader, Keyworth Primary Care Centre; and Kim-Leng Hills, patient representative), and the members of the independent data monitoring committee (Steven Julious [chair], professor of medical statistics, University of Sheffield; Ian Sabroe, professor of inflammation biology, University of Sheffield; and Stephen Scott, consultant respiratory physician, Countess of Chester Hospital).en
dc.format.extent9
dc.language.isoeng
dc.relation.ispartofThe New England Journal of Medicineen
dc.rightsFrom New England Journal of Medicine, McKeever, T., Mortimer, K., Wilson, A., Walker, S., Brightling, C., Skeggs, A., ... Harrison, T., Quadrupling Inhaled Gluococorticoid Dose To Abort Asthma Exacerbations, Vol. 378, pp. 902-910. Copyright © 2018 Massachusetts Medical Society. Reprinted with permission.en
dc.subjectR Medicine (General)en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectISRCTN15441965en
dc.subject.lccR1en
dc.titleQuadrupling Inhaled Gluococorticoid Dose To Abort Asthma Exacerbationsen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1056/NEJMoa1714257
dc.date.embargoedUntil2018-09-03
dc.identifier.vol378en
dc.identifier.iss10en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record